Innovent Biologics Grants Options, Restricted Shares Under Incentive Scheme
MT Newswires Live
2024-12-06
信达生物9.27%
Innovent Biologics (HKG:1801) granted 55,900 share options to five grantees and 488,200 restricted shares to 23 grantees under employees incentive scheme according to a Thursday filing with the Hong Kong Exchange.
The exercise price of the options is HK$38.38 per share and the exercise period of the options will not be longer than 10 years from the date of the grant.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。
热议股票
没有相关数据